;PMID: 8394214
;source_file_2936.mrg
;Release 0.9 of PennBioIE
;Funded by NSF ITR EIA-0205448

;0)section:[e:0..43] = [t:0..43]
;1)sentence:[e:49..182] = [t:49..182]
;2)section:[e:186..244] = [t:186..244]
;3)section:[e:248..337] = [t:248..337]
;4)sentence:[e:341..343] = [t:341..343]
;5)sentence:[e:344..498] = [t:344..498]
;6)sentence:[e:499..501] = [t:499..501]
;7)sentence:[e:503..802] = [t:503..802]
;8)sentence:[e:803..805] = [t:803..805]
;9)sentence:[e:806..1031] = [t:806..1031]
;10)sentence:[e:1032..1034] = [t:1032..1034]
;11)sentence:[e:1035..1270] = [t:1035..1270]
;12)sentence:[e:1271..1273] = [t:1271..1273]
;13)sentence:[e:1274..1444] = [t:1274..1444]
;14)section:[e:1448..1492] = [t:1448..1492]

;section 0 Span:0..43
;Cell Mol Neurobiol.  1993 Apr;13(2):137-45.
(SEC
  (FRAG (NNP:[0..4] Cell) (NNP:[5..8] Mol) (NNP:[9..18] Neurobiol)
        (.:[18..19] .) (CD:[21..25] 1993) (CC:[26..33] Apr;13-LRB-)
        (CD:[33..34] 2) (-RRB-:[34..35] -RRB-) (::[35..36] :)
        (CD:[36..42] 137-45) (.:[42..43] .)))

;sentence 1 Span:49..182
;Differential expression of neuron-specific enolase mRNA in mouse
;neuroblastoma  cells in response to differentiation inducing agents.
;[92..99]:gene-rna:"enolase"
;[114..127]:malignancy-type:"neuroblastoma"
(SENT
  (NP-HLN
    (NP (JJ:[49..61] Differential) (NN:[62..72] expression))
    (PP (IN:[73..75] of)
      (NP
        (ADJP (NN:[76..82] neuron) (HYPH:[82..83] -) (JJ:[83..91] specific))
        (NN:[92..99] enolase) (NN:[100..104] mRNA)))
    (PP-LOC (IN:[105..107] in)
      (NP (NN:[108..113] mouse) (NN:[114..127] neuroblastoma)
          (NNS:[129..134] cells)))
    (PP (IN:[135..137] in)
      (NP
        (NP (NN:[138..146] response))
        (PP (TO:[147..149] to)
          (NP
            (ADJP (NN:[150..165] differentiation) (VBG:[166..174] inducing))
            (NNS:[175..181] agents)))))
    (.:[181..182] .)))

;section 2 Span:186..244
;Matranga V, Oliva D, Sciarrino S, D'Amelio L, Giallongo A.
(SEC
  (FRAG (NNP:[186..194] Matranga) (NNP:[195..196] V) (,:[196..197] ,)
        (NNP:[198..203] Oliva) (NNP:[204..205] D) (,:[205..206] ,)
        (NNP:[207..216] Sciarrino) (NNP:[217..218] S) (,:[218..219] ,)
        (NNP:[220..228] D'Amelio) (NNP:[229..231] L,) (NNP:[232..241] Giallongo)
        (NNP:[242..243] A) (.:[243..244] .)))

;section 3 Span:248..337
;Istituto di Biologia dello Sviluppo, Consiglio Nazionale delle Ricerche, 
;Palermo, Italy.
(SEC
  (FRAG (NNP:[248..256] Istituto) (NNP:[257..259] di) (NNP:[260..268] Biologia)
        (NNP:[269..274] dello) (NNP:[275..283] Sviluppo) (,:[283..284] ,)
        (NNP:[285..294] Consiglio) (NNP:[295..304] Nazionale)
        (NNP:[305..310] delle) (NNP:[311..319] Ricerche) (,:[319..320] ,)
        (NNP:[322..329] Palermo) (,:[329..330] ,) (NNP:[331..336] Italy)
        (.:[336..337] .)))

;sentence 4 Span:341..343
;1.
(SENT
  (FRAG (LS:[341..343] 1.)))

;sentence 5 Span:344..498
;The mouse neuroblastoma cell line N-115 was used as a model system to study 
;neuronal differentiation induced by treatment of cells with different
;agents.
;[354..367]:malignancy-type:"neuroblastoma"
(SENT
  (S
    (NP-SBJ-1
      (NP (DT:[344..347] The) (NN:[348..353] mouse)
          (NN:[354..367] neuroblastoma) (NN:[368..372] cell)
          (NN:[373..377] line))
      (NP (NN:[378..383] N-115)))
    (VP (VBD:[384..387] was)
      (VP (VBN:[388..392] used)
        (NP-1 (-NONE-:[392..392] *))
        (PP (IN:[393..395] as)
          (NP (DT:[396..397] a) (NN:[398..403] model) (NN:[404..410] system)))
        (S-PRP
          (NP-SBJ (-NONE-:[410..410] *))
          (VP (TO:[411..413] to)
            (VP (VB:[414..419] study)
              (NP
                (NP (JJ:[421..429] neuronal) (NN:[430..445] differentiation))
                (VP (VBN:[446..453] induced)
                  (NP (-NONE-:[453..453] *))
                  (PP (IN:[454..456] by)
                    (NP-LGS
                      (NP (NN:[457..466] treatment))
                      (PP (IN:[467..469] of)
                        (NP (NNS:[470..475] cells)))
                      (PP (IN:[476..480] with)
                        (NP (JJ:[481..490] different) (NNS:[491..497] agents))))))))))))
    (.:[497..498] .)))

;sentence 6 Span:499..501
;2.
(SENT
  (FRAG (LS:[499..501] 2.)))

;sentence 7 Span:503..802
;The extent of morphological differentiation obtained with dibutyryl cyclic
;AMP  (dbc-AMP), dimethyl sulfoxide (DMSO), retinoic acid (RA), and serum-free
;medium  was correlated to the expression of the mRNA for the gamma isoform of
;the  glycolytic enzyme enolase, a recognized neuron-specific marker.
;[757..764]:gene-protein:"enolase"
(SENT
  (S
    (NP-SBJ-1
      (NP
        (NP (DT:[503..506] The) (NN:[507..513] extent))
        (PP (IN:[514..516] of)
          (NP (JJ:[517..530] morphological) (NN:[531..546] differentiation))))
      (VP (VBN:[547..555] obtained)
        (NP (-NONE-:[555..555] *))
        (PP (IN:[556..560] with)
          (NP
            (NP
              (NP (NN:[561..570] dibutyryl) (JJ:[571..577] cyclic)
                  (NN:[578..581] AMP))
              (NP (-LRB-:[583..584] -LRB-) (NN:[584..591] dbc-AMP)
                  (-RRB-:[591..592] -RRB-)))
            (,:[592..593] ,)
            (NP
              (NP (NN:[594..602] dimethyl) (NN:[603..612] sulfoxide))
              (NP (-LRB-:[613..614] -LRB-) (NN:[614..618] DMSO)
                  (-RRB-:[618..619] -RRB-)))
            (,:[619..620] ,)
            (NP
              (NP (JJ:[621..629] retinoic) (NN:[630..634] acid))
              (NP (-LRB-:[635..636] -LRB-) (NN:[636..638] RA)
                  (-RRB-:[638..639] -RRB-)))
            (,:[639..640] ,) (CC:[641..644] and)
            (NP
              (ADJP (NN:[645..650] serum) (HYPH:[650..651] -)
                    (JJ:[651..655] free))
              (NN:[656..662] medium))))))
    (VP (VBD:[664..667] was)
      (VP (VBN:[668..678] correlated)
        (NP-1 (-NONE-:[678..678] *))
        (PP (TO:[679..681] to)
          (NP
            (NP (DT:[682..685] the) (NN:[686..696] expression))
            (PP (IN:[697..699] of)
              (NP
                (NP (DT:[700..703] the) (NN:[704..708] mRNA))
                (PP (IN:[709..712] for)
                  (NP
                    (NP (DT:[713..716] the) (SYM:[717..722] gamma)
                        (NN:[723..730] isoform))
                    (PP (IN:[731..733] of)
                      (NP
                        (NP
                          (NP (DT:[734..737] the) (JJ:[739..749] glycolytic)
                              (NN:[750..756] enzyme))
                          (NP (NN:[757..764] enolase)))
                        (,:[764..765] ,)
                        (NP (DT:[766..767] a) (JJ:[768..778] recognized)
                          (ADJP (NN:[779..785] neuron) (HYPH:[785..786] -)
                                (JJ:[786..794] specific))
                          (NN:[795..801] marker))))))))))))
    (.:[801..802] .)))

;sentence 8 Span:803..805
;3.
(SENT
  (FRAG (LS:[803..805] 3.)))

;sentence 9 Span:806..1031
;A 4-day  treatment of the cells with any of the differentiation inducing
;agents used in  this study resulted in the extension of long neurites, though
;differences in  cell body shape were observed depending on the agent used.
(SENT
  (S
    (NP-SBJ
      (NP (DT:[806..807] A)
        (NML (CD:[808..809] 4) (HYPH:[809..810] -) (NN:[810..813] day))
        (NN:[815..824] treatment))
      (PP (IN:[825..827] of)
        (NP (DT:[828..831] the) (NNS:[832..837] cells)))
      (PP (IN:[838..842] with)
        (NP
          (NP (DT:[843..846] any))
          (PP (IN:[847..849] of)
            (NP
              (NP (DT:[850..853] the)
                (ADJP (NN:[854..869] differentiation) (VBG:[870..878] inducing))
                (NNS:[879..885] agents))
              (VP (VBN:[886..890] used)
                (NP (-NONE-:[890..890] *))
                (PP (IN:[891..893] in)
                  (NP (DT:[895..899] this) (NN:[900..905] study)))))))))
    (VP (VBD:[906..914] resulted)
      (PP (IN:[915..917] in)
        (NP
          (NP (DT:[918..921] the) (NN:[922..931] extension))
          (PP (IN:[932..934] of)
            (NP (JJ:[935..939] long) (NNS:[940..948] neurites)))))
      (,:[948..949] ,)
      (SBAR-ADV (IN:[950..956] though)
        (S
          (NP-SBJ-1
            (NP (NNS:[957..968] differences))
            (PP (IN:[969..971] in)
              (NP (NN:[973..977] cell) (NN:[978..982] body)
                  (NN:[983..988] shape))))
          (VP (VBD:[989..993] were)
            (VP (VBN:[994..1002] observed)
              (NP-1 (-NONE-:[1002..1002] *))
              (S-ADV
                (NP-SBJ (-NONE-:[1002..1002] *))
                (VP (VBG:[1003..1012] depending)
                  (PP-CLR (IN:[1013..1015] on)
                    (NP
                      (NP (DT:[1016..1019] the) (NN:[1020..1025] agent))
                      (VP (VBN:[1026..1030] used)
                        (NP (-NONE-:[1030..1030] *))))))))))))
    (.:[1030..1031] .)))

;sentence 10 Span:1032..1034
;4.
(SENT
  (FRAG (LS:[1032..1034] 4.)))

;sentence 11 Span:1035..1270
;Northern blot  analysis revealed that changes in the level of gamma
;enolase-specific mRNA  correlate with the extent of morphological
;differentiation, with a 5- to 20-fold  increase depending on the
;differentiation inducing agent used.
;[1097..1110]:gene-rna:"gamma enolase"
(SENT
  (S
    (NP-SBJ (JJ:[1035..1043] Northern) (NN:[1044..1048] blot)
            (NN:[1050..1058] analysis))
    (VP (VBD:[1059..1067] revealed)
      (SBAR (IN:[1068..1072] that)
        (S
          (NP-SBJ
            (NP (NNS:[1073..1080] changes))
            (PP (IN:[1081..1083] in)
              (NP
                (NP (DT:[1084..1087] the) (NN:[1088..1093] level))
                (PP (IN:[1094..1096] of)
                  (NP
                    (ADJP
                      (NML (SYM:[1097..1102] gamma) (NN:[1103..1110] enolase))
                      (HYPH:[1110..1111] -) (JJ:[1111..1119] specific))
                    (NN:[1120..1124] mRNA))))))
          (VP (VBP:[1126..1135] correlate)
            (PP (IN:[1136..1140] with)
              (NP
                (NP (DT:[1141..1144] the) (NN:[1145..1151] extent))
                (PP (IN:[1152..1154] of)
                  (NP (JJ:[1155..1168] morphological)
                      (NN:[1169..1184] differentiation)))))
            (,:[1184..1185] ,)
            (PP (IN:[1186..1190] with)
              (NP
                (NP (DT:[1191..1192] a)
                  (ADJP
                    (QP (CD:[1193..1194] 5) (HYPH:[1194..1195] -)
                        (TO:[1196..1198] to) (CD:[1199..1201] 20))
                    (HYPH:[1201..1202] -) (JJ:[1202..1206] fold))
                  (NN:[1208..1216] increase))
                (VP (VBG:[1217..1226] depending)
                  (PP-CLR (IN:[1227..1229] on)
                    (NP
                      (NP (DT:[1230..1233] the)
                        (ADJP (NN:[1234..1249] differentiation)
                              (VBG:[1250..1258] inducing))
                        (NN:[1259..1264] agent))
                      (VP (VBN:[1265..1269] used)
                        (NP (-NONE-:[1269..1269] *))))))))))))
    (.:[1269..1270] .)))

;sentence 12 Span:1271..1273
;5.
(SENT
  (FRAG (LS:[1271..1273] 5.)))

;sentence 13 Span:1274..1444
;Finally, we  found that a high cell density causes a significative increase
;in the level of  the gamma enolase-specific message in cells maintained in
;growing conditions.
;[1371..1384]:gene-generic:"gamma enolase"
(SENT
  (S
    (ADVP (RB:[1274..1281] Finally))
    (,:[1281..1282] ,)
    (NP-SBJ (PRP:[1283..1285] we))
    (VP (VBD:[1287..1292] found)
      (SBAR (IN:[1293..1297] that)
        (S
          (NP-SBJ (DT:[1298..1299] a) (JJ:[1300..1304] high)
                  (NN:[1305..1309] cell) (NN:[1310..1317] density))
          (VP (VBZ:[1318..1324] causes)
            (NP
              (NP (DT:[1325..1326] a) (JJ:[1327..1340] significative)
                  (NN:[1341..1349] increase))
              (PP (IN:[1350..1352] in)
                (NP
                  (NP (DT:[1353..1356] the) (NN:[1357..1362] level))
                  (PP (IN:[1363..1365] of)
                    (NP (DT:[1367..1370] the)
                      (ADJP
                         (SYM:[1371..1376] gamma) (NN:[1377..1384] enolase)
                        (HYPH:[1384..1385] -) (JJ:[1385..1393] specific))
                      (NN:[1394..1401] message)))))
              (PP-LOC (IN:[1402..1404] in)
                (NP
                  (NP (NNS:[1405..1410] cells))
                  (VP (VBN:[1411..1421] maintained)
                    (NP (-NONE-:[1421..1421] *))
                    (PP (IN:[1422..1424] in)
                      (NP (NN:[1425..1432] growing)
                          (NNS:[1433..1443] conditions)))))))))))
    (.:[1443..1444] .)))

;section 14 Span:1448..1492
;PMID: 8394214 [PubMed - indexed for MEDLINE]
(SEC
  (FRAG (NNP:[1448..1452] PMID) (::[1452..1453] :) (CD:[1454..1461] 8394214)
        (NN:[1462..1463] -LSB-) (NNP:[1463..1469] PubMed) (::[1470..1471] -)
        (NN:[1472..1479] indexed) (IN:[1480..1483] for)
        (NNP:[1484..1492] MEDLINE-RSB-)))
